Back
Speaker illustration

Doctor Maarten Blondeel

KU Leuven, Leuven (Belgium)

Member of:

European Society of Cardiology

Presentations

Incidence and clinical implications of de novo clinical and subclinical atrial fibrillation in implantable cardioverter-defibrillator recipients with ischemic or non-ischemic cardiomyopathy

Event: ESC Congress 2025

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Atrial fibrillation: from environmental triggers to outcomes

Access
Like
Thumbnail

Implantable cardioverter defibrillator resistant mortality in ischemic and dilated cardiomyopathy across therapeutic eras: a single, tertiary center experience

Event: EHRA 2025

Topic: Device Treatment

Session: Device therapy (2)

Access
Like
Thumbnail

QRS-microfragmentation and non-planarity as predictors of clinical outcome and left ventricular ejection fraction improvement following cardiac resychronization therapy

Event: EHRA 2025

Topic: Electrocardiography (ECG)

Session: ECG and rhythm monitoring

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources